Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer.
Zheng H, Tie Y, Fang Z, Wu X, Yi T, Huang S, Liang X, Qian Y, Wang X, Pi R, Chen S, Peng Y, Yang S, Zhao X, Wei X.
Zheng H, et al. Among authors: pi r.
Signal Transduct Target Ther. 2019 Jul 26;4:24. doi: 10.1038/s41392-019-0055-8. eCollection 2019.
Signal Transduct Target Ther. 2019.
PMID: 31637004
Free PMC article.